Ventilator-Associated Pneumonia in Immunosuppressed Patients
Abstract
:1. Introduction
2. Methods
3. Incidence of VAP in Immunosuppressed Patients
4. Diagnosis
5. Microbiology
6. Impact of Immunosuppression on Outcomes in VAP and VAT Patients
7. Treatment of VAP in Immunosuppressed Patients
8. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
BAL | bronchoalveolar lavage |
CMV | cytomegalovirus |
CT | computed tomograpy |
FOB | fiberoptic bronchoscopy |
HR | hazard ratio |
HSCT | hematopoietic stem cell transplantation |
HSV | herpes simplex virus |
IPA | invasive pulmonary aspergillosis |
MDR | multidrug-resistant |
mNGS | metagenomic next-generation sequencing |
OR | odds ratio |
VA-LTRI | ventilator-associated lower respiratory tract infection |
VAP | ventilator-associated pneumonia |
VAT | ventilator-associated tracheobronchitis |
References
- Dumas, G.; Lemiale, V.; Rathi, N.; Cortegiani, A.; Pène, F.; Bonny, V.; Salluh, J.; Albaiceta, G.M.; Soares, M.; Soubani, A.O.; et al. Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis. Am. J. Respir. Crit. Care Med. 2021, 204, 187–196. [Google Scholar] [CrossRef] [PubMed]
- Florescu, D.F.; Sandkovsky, U.; Kalil, A.C. Sepsis and Challenging Infections in the Immunosuppressed Patient in the Intensive Care Unit. Infect. Dis. Clin. N. Am. 2017, 31, 415–434. [Google Scholar] [CrossRef] [PubMed]
- Moreau, A.-S.; Martin-Loeches, I.; Povoa, P.; Salluh, J.; Rodriguez, A.; Thille, A.W.; Diaz Santos, E.; Vedes, E.; Lobo, S.M.; Mégarbane, B.; et al. Impact of Immunosuppression on Incidence, Aetiology and Outcome of Ventilator-Associated Lower Respiratory Tract Infections. Eur. Respir. J. 2018, 51, 1701656. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Riera, J.; Caralt, B.; López, I.; Augustin, S.; Roman, A.; Gavalda, J.; Rello, J.; Vall d’Hebron Lung Transplant Study Group. Ventilator-Associated Respiratory Infection Following Lung Transplantation. Eur. Respir. J. 2015, 45, 726–737. [Google Scholar] [CrossRef] [Green Version]
- Siniscalchi, A.; Aurini, L.; Benini, B.; Gamberini, L.; Nava, S.; Viale, P.; Faenza, S. Ventilator Associated Pneumonia Following Liver Transplantation: Etiology, Risk Factors and Outcome. World J. Transplant. 2016, 6, 389–395. [Google Scholar] [CrossRef] [Green Version]
- Mesland, J.-B.; Carlier, E.; François, B.; Serck, N.; Gerard, L.; Briat, C.; Piagnerelli, M.; Laterre, P.-F.; On Behalf Of The Covcorvap Collaboration Group. Early Corticosteroid Therapy May Increase Ventilator-Associated Lower Respiratory Tract Infection in Critically Ill Patients with COVID-19: A Multicenter Retrospective Cohort Study. Microorganisms 2022, 10, 984. [Google Scholar] [CrossRef]
- Martínez-Martínez, M.; Plata-Menchaca, E.P.; Nuvials, F.X.; Roca, O.; Ferrer, R. Risk Factors and Outcomes of Ventilator-Associated Pneumonia in COVID-19 Patients: A Propensity Score Matched Analysis. Crit. Care 2021, 25, 235. [Google Scholar] [CrossRef]
- Torres, A.; Niederman, M.S.; Chastre, J.; Ewig, S.; Fernandez-Vandellos, P.; Hanberger, H.; Kollef, M.; Li Bassi, G.; Luna, C.M.; Martin-Loeches, I.; et al. International ERS/ESICM/ESCMID/ALAT Guidelines for the Management of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: Guidelines for the Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-Associated Pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana Del Tórax (ALAT). Eur. Respir. J. 2017, 50, 1700582. [Google Scholar] [CrossRef] [Green Version]
- Kontoyiannis, D.P. Rational Approach to Pulmonary Infiltrates in Leukemia and Transplantation. Best Pract. Res. Clin. Haematol. 2013, 26, 301–306. [Google Scholar] [CrossRef]
- Miller, W.T.; Mickus, T.J.; Barbosa, E.; Mullin, C.; Van Deerlin, V.M.; Shiley, K.T. CT of Viral Lower Respiratory Tract Infections in Adults: Comparison among Viral Organisms and between Viral and Bacterial Infections. AJR Am. J. Roentgenol. 2011, 197, 1088–1095. [Google Scholar] [CrossRef]
- Koo, H.J.; Lim, S.; Choe, J.; Choi, S.-H.; Sung, H.; Do, K.-H. Radiographic and CT Features of Viral Pneumonia. Radiographics 2018, 38, 719–739. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Luyt, C.-E.; Combes, A.; Reynaud, C.; Hekimian, G.; Nieszkowska, A.; Tonnellier, M.; Aubry, A.; Trouillet, J.-L.; Bernard, M.; Chastre, J. Usefulness of Procalcitonin for the Diagnosis of Ventilator-Associated Pneumonia. Intensive Care Med. 2008, 34, 1434–1440. [Google Scholar] [CrossRef] [PubMed]
- Póvoa, P.; Martin-Loeches, I.; Ramirez, P.; Bos, L.D.; Esperatti, M.; Silvestre, J.; Gili, G.; Goma, G.; Berlanga, E.; Espasa, M.; et al. Biomarker Kinetics in the Prediction of VAP Diagnosis: Results from the BioVAP Study. Ann. Intensive Care 2016, 6, 32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sandherr, M.; Hentrich, M.; von Lilienfeld-Toal, M.; Massenkeil, G.; Neumann, S.; Penack, O.; Biehl, L.; Cornely, O.A. Antiviral Prophylaxis in Patients with Solid Tumours and Haematological Malignancies—Update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann. Hematol. 2015, 94, 1441–1450. [Google Scholar] [CrossRef] [Green Version]
- Kanamori, H.; Rutala, W.A.; Sickbert-Bennett, E.E.; Weber, D.J. Review of Fungal Outbreaks and Infection Prevention in Healthcare Settings during Construction and Renovation. Clin. Infect. Dis. 2015, 61, 433–444. [Google Scholar] [CrossRef]
- Azoulay, E.; Mokart, D.; Lambert, J.; Lemiale, V.; Rabbat, A.; Kouatchet, A.; Vincent, F.; Gruson, D.; Bruneel, F.; Epinette-Branche, G.; et al. Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure: Randomized Controlled Trial. Am. J. Respir. Crit. Care Med. 2010, 182, 1038–1046. [Google Scholar] [CrossRef] [Green Version]
- Luyt, C.-E.; Combes, A.; Deback, C.; Aubriot-Lorton, M.-H.; Nieszkowska, A.; Trouillet, J.-L.; Capron, F.; Agut, H.; Gibert, C.; Chastre, J. Herpes Simplex Virus Lung Infection in Patients Undergoing Prolonged Mechanical Ventilation. Am. J. Respir. Crit. Care Med. 2007, 175, 935–942. [Google Scholar] [CrossRef]
- Ljungman, P.; Boeckh, M.; Hirsch, H.H.; Josephson, F.; Lundgren, J.; Nichols, G.; Pikis, A.; Razonable, R.R.; Miller, V.; Griffiths, P.D.; et al. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clin. Infect. Dis. 2017, 64, 87–91. [Google Scholar] [CrossRef] [Green Version]
- Mirouse, A.; Vignon, P.; Piron, P.; Robert, R.; Papazian, L.; Géri, G.; Blanc, P.; Guitton, C.; Guérin, C.; Bigé, N.; et al. Severe Varicella-Zoster Virus Pneumonia: A Multicenter Cohort Study. Crit. Care 2017, 21, 137. [Google Scholar] [CrossRef] [Green Version]
- Lee, H.Y.; Rhee, C.K.; Choi, J.Y.; Lee, H.Y.; Lee, J.W.; Lee, D.G. Diagnosis of Cytomegalovirus Pneumonia by Quantitative Polymerase Chain Reaction Using Bronchial Washing Fluid from Patients with Hematologic Malignancies. Oncotarget 2017, 8, 39736–39745. [Google Scholar] [CrossRef] [Green Version]
- Loughlin, L.; Hellyer, T.P.; White, P.L.; McAuley, D.F.; Conway Morris, A.; Posso, R.B.; Richardson, M.D.; Denning, D.W.; Simpson, A.J.; McMullan, R. Pulmonary Aspergillosis in Patients with Suspected Ventilator-Associated Pneumonia in UK ICUs. Am. J. Respir. Crit. Care Med. 2020, 202, 1125–1132. [Google Scholar] [CrossRef] [PubMed]
- Hage, C.A.; Carmona, E.M.; Epelbaum, O.; Evans, S.E.; Gabe, L.M.; Haydour, Q.; Knox, K.S.; Kolls, J.K.; Murad, M.H.; Wengenack, N.L.; et al. Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline. Am. J. Respir. Crit. Care Med. 2019, 200, 535–550. [Google Scholar] [CrossRef] [PubMed]
- Strålin, K.; Ehn, F.; Giske, C.G.; Ullberg, M.; Hedlund, J.; Petersson, J.; Spindler, C.; Özenci, V. The IRIDICA PCR/Electrospray Ionization-Mass Spectrometry Assay on Bronchoalveolar Lavage for Bacterial Etiology in Mechanically Ventilated Patients with Suspected Pneumonia. PLoS ONE 2016, 11, e0159694. [Google Scholar] [CrossRef] [PubMed]
- Hou, D.; Ju, M.; Wang, Y.; Zhang, D.; Zhu, D.; Zhong, M.; Zhou, C.; Song, Y.; Cheng, X. PCR Coupled to Electrospray Ionization Mass Spectrometry for Microbiological Diagnosis and Surveillance of Ventilator-Associated Pneumonia. Exp. Ther. Med. 2020, 20, 3587–3594. [Google Scholar] [CrossRef]
- Vasala, A.; Hytönen, V.P.; Laitinen, O.H. Modern Tools for Rapid Diagnostics of Antimicrobial Resistance. Front. Cell. Infect. Microbiol. 2020, 10, 308. [Google Scholar] [CrossRef]
- Darie, A.M.; Khanna, N.; Jahn, K.; Osthoff, M.; Bassetti, S.; Osthoff, M.; Schumann, D.M.; Albrich, W.C.; Hirsch, H.; Brutsche, M.; et al. Fast Multiplex Bacterial PCR of Bronchoalveolar Lavage for Antibiotic Stewardship in Hospitalised Patients with Pneumonia at Risk of Gram-Negative Bacterial Infection (Flagship II): A Multicentre, Randomised Controlled Trial. Lancet Respir. Med. 2022, 10, 877–887. [Google Scholar] [CrossRef]
- Fang, X.; Mei, Q.; Fan, X.; Zhu, C.; Yang, T.; Zhang, L.; Geng, S.; Pan, A. Diagnostic Value of Metagenomic Next-Generation Sequencing for the Detection of Pathogens in Bronchoalveolar Lavage Fluid in Ventilator-Associated Pneumonia Patients. Front. Microbiol. 2020, 11, 599756. [Google Scholar] [CrossRef]
- Li, J.; Zhou, C.-E.; Wei, S.-C.; Wang, L.-N.; Shi, M.-W.; Sun, C.-P.; Lin, L.-J.; Liu, X.-M. Diagnostic Value of Metagenomic Next-Generation Sequencing for Pneumonia in Immunocompromised Patients. Can. J. Infect. Dis. Med. Microbiol. 2022, 2022, 5884568. [Google Scholar] [CrossRef]
- Schnabel, R.M.; van der Velden, K.; Osinski, A.; Rohde, G.; Roekaerts, P.M.H.J.; Bergmans, D.C.J.J. Clinical Course and Complications Following Diagnostic Bronchoalveolar Lavage in Critically Ill Mechanically Ventilated Patients. BMC Pulm. Med. 2015, 15, 107. [Google Scholar] [CrossRef] [Green Version]
- Faiz, S.A.; Jimenez, C.A.; Fellman, B.M.; Huk, T.; Jazbeh, S.; Haque, S.A.; Morice, R.C.; Grosu, H.B.; Balachandran, D.D.; Shannon, V.R.; et al. Incidence of Bleeding Complications with Flexible Bronchoscopy in Cancer Patients with Thrombocytopenia. J. Bronchol. Interv. Pulmonol. 2019, 26, 280–286. [Google Scholar] [CrossRef]
- Kamel, T.; Helms, J.; Janssen-Langenstein, R.; Kouatchet, A.; Guillon, A.; Bourenne, J.; Contou, D.; Guervilly, C.; Coudroy, R.; Hoppe, M.A.; et al. Benefit-to-Risk Balance of Bronchoalveolar Lavage in the Critically Ill. A Prospective, Multicenter Cohort Study. Intensive Care Med. 2020, 46, 463–474. [Google Scholar] [CrossRef]
- Martin-Loeches, I.; Chastre, J.; Wunderink, R.G. Bronchoscopy for Diagnosis of Ventilator-Associated Pneumonia. Intensive Care Med. 2023, 49, 79–82. [Google Scholar] [CrossRef] [PubMed]
- Papazian, L.; Klompas, M.; Luyt, C.-E. Ventilator-Associated Pneumonia in Adults: A Narrative Review. Intensive Care Med. 2020, 46, 888–906. [Google Scholar] [CrossRef] [Green Version]
- Gudiol, C.; Sabé, N.; Carratalà, J. Is Hospital-Acquired Pneumonia Different in Transplant Recipients? Clin. Microbiol. Infect. 2019, 25, 1186–1194. [Google Scholar] [CrossRef] [PubMed]
- Aguilar-Guisado, M.; Jiménez-Jambrina, M.; Espigado, I.; Rovira, M.; Martino, R.; Oriol, A.; Borrell, N.; Ruiz, I.; Martín-Dávila, P.; de la Cámara, R.; et al. Pneumonia in Allogeneic Stem Cell Transplantation Recipients: A Multicenter Prospective Study. Clin. Transplant. 2011, 25, E629–E638. [Google Scholar] [CrossRef]
- Cillóniz, C.; Dominedò, C.; Torres, A. An Overview of Guidelines for the Management of Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria. Curr. Opin. Infect. Dis. 2019, 32, 656. [Google Scholar] [CrossRef]
- Luyt, C.-E.; Hékimian, G.; Koulenti, D.; Chastre, J. Microbial Cause of ICU-Acquired Pneumonia: Hospital-Acquired Pneumonia versus Ventilator-Associated Pneumonia. Curr. Opin. Crit. Care 2018, 24, 332–338. [Google Scholar] [CrossRef] [PubMed]
- Rhodes, N.J.; Cruce, C.E.; O’Donnell, J.N.; Wunderink, R.G.; Hauser, A.R. Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia. Curr. Infect. Dis. Rep. 2018, 20, 3. [Google Scholar] [CrossRef] [PubMed]
- Martin-Loeches, I.; Povoa, P.; Rodríguez, A.; Curcio, D.; Suarez, D.; Mira, J.-P.; Cordero, M.L.; Lepecq, R.; Girault, C.; Candeias, C.; et al. Incidence and Prognosis of Ventilator-Associated Tracheobronchitis (TAVeM): A Multicentre, Prospective, Observational Study. Lancet Respir. Med. 2015, 3, 859–868. [Google Scholar] [CrossRef]
- European Centre for Disease Prevention and Control. Surveillance of Antimicrobial Resistance in Europe 2018; ECDC: Stockholm, Sweden, 2019.
- Guillamet, C.V.; Kollef, M.H. Update on Ventilator-Associated Pneumonia. Curr. Opin. Crit. Care 2015, 21, 430–438. [Google Scholar] [CrossRef]
- Kalil, A.C.; Metersky, M.L.; Klompas, M.; Muscedere, J.; Sweeney, D.A.; Palmer, L.B.; Napolitano, L.M.; O’Grady, N.P.; Bartlett, J.G.; Carratalà, J.; et al. Management of Adults with Hospital-Acquired and Ventilator-Associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin. Infect. Dis. 2016, 63, e61–e111. [Google Scholar] [CrossRef] [Green Version]
- Shindo, Y.; Ito, R.; Kobayashi, D.; Ando, M.; Ichikawa, M.; Shiraki, A.; Goto, Y.; Fukui, Y.; Iwaki, M.; Okumura, J.; et al. Risk Factors for Drug-Resistant Pathogens in Community-Acquired and Healthcare-Associated Pneumonia. Am. J. Respir. Crit. Care Med. 2013, 188, 985–995. [Google Scholar] [CrossRef] [PubMed]
- Dumford, D.M.; Skalweit, M. Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host. Infect. Dis. Clin. N. Am. 2016, 30, 465–489. [Google Scholar] [CrossRef] [PubMed]
- Dumford, D.; Skalweit, M.J. Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host: An Update. Infect. Dis. Clin. N. Am. 2020, 34, 821–847. [Google Scholar] [CrossRef] [PubMed]
- American Thoracic Society; Infectious Diseases Society of America. Guidelines for the Management of Adults with Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia. Am. J. Respir. Crit. Care Med. 2005, 171, 388–416. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kreitmann, L.; Vasseur, M.; Jermoumi, S.; Perche, J.; Richard, J.-C.; Wallet, F.; Chabani, M.; Nourry, E.; Garçon, P.; Zerbib, Y.; et al. Relationship between Immunosuppression and Intensive Care Unit-Acquired Colonization and Infection Related to Multidrug-Resistant Bacteria: A Prospective Multicenter Cohort Study. Intensive Care Med. 2023, 35, 1318–1323. [Google Scholar] [CrossRef] [PubMed]
- Donnelly, J.P.; Chen, S.C.; Kauffman, C.A.; Steinbach, W.J.; Baddley, J.W.; Verweij, P.E.; Clancy, C.J.; Wingard, J.R.; Lockhart, S.R.; Groll, A.H.; et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin. Infect. Dis. 2020, 71, 1367–1376. [Google Scholar] [CrossRef] [Green Version]
- Chen, F.; Qasir, D.; Morris, A.C. Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias. Semin. Respir. Crit. Care Med. 2022, 43, 234–242. [Google Scholar] [CrossRef]
- Schauwvlieghe, A.F.A.D.; Rijnders, B.J.A.; Philips, N.; Verwijs, R.; Vanderbeke, L.; Tienen, C.V.; Lagrou, K.; Verweij, P.E.; de Veerdonk, F.L.V.; Gommers, D.; et al. Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit with Severe Influenza: A Retrospective Cohort Study. Lancet Respir. Med. 2018, 6, 782–792. [Google Scholar] [CrossRef]
- Rouzé, A.; Lemaitre, E.; Martin-Loeches, I.; Povoa, P.; Diaz, E.; Nyga, R.; Torres, A.; Metzelard, M.; Du Cheyron, D.; Lambiotte, F.; et al. Invasive Pulmonary Aspergillosis among Intubated Patients with SARS-CoV-2 or Influenza Pneumonia: A European Multicenter Comparative Cohort Study. Crit. Care 2022, 26, 11. [Google Scholar] [CrossRef]
- Taccone, F.S.; Van den Abeele, A.-M.; Bulpa, P.; Misset, B.; Meersseman, W.; Cardoso, T.; Paiva, J.-A.; Blasco-Navalpotro, M.; De Laere, E.; Dimopoulos, G.; et al. Epidemiology of Invasive Aspergillosis in Critically Ill Patients: Clinical Presentation, Underlying Conditions, and Outcomes. Crit. Care 2015, 19, 7. [Google Scholar] [CrossRef] [Green Version]
- Williams, K.M.; Ahn, K.W.; Chen, M.; Aljurf, M.D.; Agwu, A.L.; Chen, A.R.; Walsh, T.J.; Szabolcs, P.; Boeckh, M.J.; Auletta, J.J.; et al. The Incidence, Mortality and Timing of Pneumocystis Jiroveci Pneumonia after Hematopoietic Cell Transplantation: A CIBMTR Analysis. Bone Marrow Transplant. 2016, 51, 573–580. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Iriart, X.; Challan Belval, T.; Fillaux, J.; Esposito, L.; Lavergne, R.-A.; Cardeau-Desangles, I.; Roques, O.; Del Bello, A.; Cointault, O.; Lavayssière, L.; et al. Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis. Am. J. Transplant. 2015, 15, 190–199. [Google Scholar] [CrossRef] [PubMed]
- Fishman, J.A. Infection in Organ Transplantation. Am. J. Transplant. 2017, 17, 856–879. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Singh, N.; Alexander, B.D.; Lortholary, O.; Dromer, F.; Gupta, K.L.; John, G.T.; del Busto, R.; Klintmalm, G.B.; Somani, J.; Lyon, G.M.; et al. Pulmonary Cryptococcosis in Solid Organ Transplant Recipients: Clinical Relevance of Serum Cryptococcal Antigen. Clin. Infect. Dis. 2008, 46, e12–e18. [Google Scholar] [CrossRef] [PubMed]
- Shoham, S.; Marr, K.A. Invasive Fungal Infections in Solid Organ Transplant Recipients. Future Microbiol. 2012, 7, 639–655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fàbregas, N.; Torres, A.; El-Ebiary, M.; Ramírez, J.; Hernández, C.; González, J.; de la Bellacasa, J.P.; de Anta, J.; Rodriguez-Roisin, R. Histopathologic and Microbiologic Aspects of Ventilator-Associated Pneumonia. Anesthesiology 1996, 84, 760–771. [Google Scholar] [CrossRef]
- van Someren Gréve, F.; Juffermans, N.P.; Bos, L.D.J.; Binnekade, J.M.; Braber, A.; Cremer, O.L.; de Jonge, E.; Molenkamp, R.; Ong, D.S.Y.; Rebers, S.P.H.; et al. Respiratory Viruses in Invasively Ventilated Critically Ill Patients-A Prospective Multicenter Observational Study. Crit. Care Med. 2018, 46, 29–36. [Google Scholar] [CrossRef] [Green Version]
- Legoff, J.; Zucman, N.; Lemiale, V.; Mokart, D.; Pène, F.; Lambert, J.; Kouatchet, A.; Demoule, A.; Vincent, F.; Nyunga, M.; et al. Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology Patients. Am. J. Respir. Crit. Care Med. 2019, 199, 518–528. [Google Scholar] [CrossRef] [Green Version]
- Papazian, L.; Hraiech, S.; Lehingue, S.; Roch, A.; Chiche, L.; Wiramus, S.; Forel, J.-M. Cytomegalovirus Reactivation in ICU Patients. Intensive Care Med. 2016, 42, 28–37. [Google Scholar] [CrossRef]
- Melsen, W.G.; Rovers, M.M.; Groenwold, R.H.H.; Bergmans, D.C.J.J.; Camus, C.; Bauer, T.T.; Hanisch, E.W.; Klarin, B.; Koeman, M.; Krueger, W.A.; et al. Attributable Mortality of Ventilator-Associated Pneumonia: A Meta-Analysis of Individual Patient Data from Randomised Prevention Studies. Lancet Infect. Dis. 2013, 13, 665–671. [Google Scholar] [CrossRef] [PubMed]
- Bekaert, M.; Timsit, J.-F.; Vansteelandt, S.; Depuydt, P.; Vésin, A.; Garrouste-Orgeas, M.; Decruyenaere, J.; Clec’h, C.; Azoulay, E.; Benoit, D.; et al. Attributable Mortality of Ventilator-Associated Pneumonia: A Reappraisal Using Causal Analysis. Am. J. Respir. Crit. Care Med. 2011, 184, 1133–1139. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Steen, J.; Vansteelandt, S.; De Bus, L.; Depuydt, P.; Gadeyne, B.; Benoit, D.D.; Decruyenaere, J. Attributable Mortality of Ventilator-Associated Pneumonia. Replicating Findings, Revisiting Methods. Ann. Am. Thorac. Soc. 2021, 18, 830–837. [Google Scholar] [CrossRef] [PubMed]
- Timsit, J.-F.; Zahar, J.-R.; Chevret, S. Attributable Mortality of Ventilator-Associated Pneumonia. Curr. Opin. Crit. Care 2011, 17, 464–471. [Google Scholar] [CrossRef] [PubMed]
- Siempos, I.I.; Vardakas, K.Z.; Kyriakopoulos, C.E.; Ntaidou, T.K.; Falagas, M.E. Predictors of Mortality in Adult Patients with Ventilator-Associated Pneumonia: A Meta-Analysis. Shock 2010, 33, 590–601. [Google Scholar] [CrossRef] [PubMed]
- Inchai, J.; Pothirat, C.; Liwsrisakun, C.; Deesomchok, A.; Kositsakulchai, W.; Chalermpanchai, N. Ventilator-Associated Pneumonia: Epidemiology and Prognostic Indicators of 30-Day Mortality. Jpn. J. Infect. Dis. 2015, 68, 181–186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pellegrino, C.M.; Codeluppi, M.; Assenza, S.; Cocchi, S.; Di Benedetto, F.; Girardis, M. Incidence and Clinical Outcomes of Ventilator-Associated Pneumonia in Liver Transplant and Non-Liver Transplant Surgical Patients. Transplant. Proc. 2008, 40, 1986–1988. [Google Scholar] [CrossRef]
- de Castro-Lima, V.A.C.; Borges, I.C.; Joelsons, D.; Sales, V.V.T.; Guimaraes, T.; Ho, Y.L.; Costa, S.F.; Moura, M.L.N. Impact of Human Immunodeficiency Virus Infection on Mortality of Patients Who Acquired Healthcare Associated-Infection in Critical Care Unit. Medicine 2019, 98, e15801. [Google Scholar] [CrossRef]
- Nseir, S.; Martin-Loeches, I.; Makris, D.; Jaillette, E.; Karvouniaris, M.; Valles, J.; Zakynthinos, E.; Artigas, A. Impact of Appropriate Antimicrobial Treatment on Transition from Ventilator-Associated Tracheobronchitis to Ventilator-Associated Pneumonia. Crit. Care 2014, 18, R129. [Google Scholar] [CrossRef] [Green Version]
- Safdar, N.; Dezfulian, C.; Collard, H.R.; Saint, S. Clinical and Economic Consequences of Ventilator-Associated Pneumonia: A Systematic Review. Crit. Care Med. 2005, 33, 2184–2193. [Google Scholar] [CrossRef]
- Nseir, S.; Di Pompeo, C.; Diarra, M.; Brisson, H.; Tissier, S.; Boulo, M.; Durocher, A. Relationship between Immunosuppression and Intensive Care Unit-Acquired Multidrug-Resistant Bacteria: A Case-Control Study. Crit. Care Med. 2007, 35, 1318–1323. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kreitmann, L.; Gaudet, A.; Nseir, S. Ventilator-Associated Pneumonia in Immunosuppressed Patients. Antibiotics 2023, 12, 413. https://doi.org/10.3390/antibiotics12020413
Kreitmann L, Gaudet A, Nseir S. Ventilator-Associated Pneumonia in Immunosuppressed Patients. Antibiotics. 2023; 12(2):413. https://doi.org/10.3390/antibiotics12020413
Chicago/Turabian StyleKreitmann, Louis, Alexandre Gaudet, and Saad Nseir. 2023. "Ventilator-Associated Pneumonia in Immunosuppressed Patients" Antibiotics 12, no. 2: 413. https://doi.org/10.3390/antibiotics12020413
APA StyleKreitmann, L., Gaudet, A., & Nseir, S. (2023). Ventilator-Associated Pneumonia in Immunosuppressed Patients. Antibiotics, 12(2), 413. https://doi.org/10.3390/antibiotics12020413